GlassScriptPhysician profile
Angela Jarvis
NPI 1962409177
$1,269.28
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,168 · 2020: $82.43 · 2022: $19.05.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $144.22 | 2019-2020 | |
| Amarin Pharma, INC. | $131.88 | 2019 | |
| Pfizer INC. | $130.06 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $125.69 | 2019 | |
| Novo Nordisk INC | $125.33 | 2019 | |
| Lilly USA, LLC | $117.68 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.27 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.17 | 2019-2020 | |
| Abbvie INC. | $41.61 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $41.19 | 2019 | |
| Ironshore Pharmaceuticals INC. | $39.19 | 2019 | |
| Sanofi-Aventis U.S. LLC | $35.05 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $34.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $32.50 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.80 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $26.47 | 2020 | |
| Horizon Therapeutics Plc | $25.38 | 2019 | |
| Genentech USA, INC. | $24.80 | 2019-2020 | |
| Shire North American Group INC | $14.17 | 2019 | |
| Mylan Specialty L.P. | $12.50 | 2019 | |
| Sanofi Pasteur INC. | $11.22 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $10.89 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Jarvis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.